Trials / Recruiting
RecruitingNCT07127926
Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic Graft Versus Host Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to evaluate belumosudil pharmacokinetics of whole tablets and crushed tablets suspended in water in patients suffering from chronic graft-versus-host disease (cGVHD).
Detailed description
Primary Objective: To evaluate belumosudil pharmacokinetics of whole tablets and crushed tablets suspended in water in patients suffering from chronic graft-versus-host disease (cGVHD).
Conditions
Timeline
- Start date
- 2026-02-09
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2025-08-17
- Last updated
- 2026-02-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07127926. Inclusion in this directory is not an endorsement.